Evidence map›Paper›PMID 33507339›Full record

ArticleArchives of microbiology2021

Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.

Branka Bedenić, Sanda Sardelić, Maja Bogdanić, Gernot Zarfel, Nataša Beader, Sandra Šuto, Marija Krilanović, Jasmina Vraneš

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Mutation analysis of dihydrofolate reductase (Iranian journal of microbiology · 2026
    Article
  2. Article
  3. In vitro antimicrobial activity and clinical use of trimethoprim-sulfamethoxazole for infections due to KPC-producing Gram-negative pathogens: a review.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Branka BedenićSchool of Medicine, University of Zagreb, Zagreb, Croatia. branka.bedenic@kbc-zagreb.hr.ORCID http://orcid.org/0000-0002-5946-7997
Sanda SardelićUniversity Hospital Center Split, Split, Croatia.
Maja BogdanićNational Public Health Institute, Zagreb, Croatia.
Gernot ZarfelInstitute for Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.
Nataša BeaderSchool of Medicine, University of Zagreb, Zagreb, Croatia.
Sandra ŠutoAndrija Štampar Teaching Public Health Institute, Zagreb, Croatia.
Marija KrilanovićPublic Health Institute of Dubrovnik-Neretva County, Dubrovnik, Croatia.
Jasmina VranešSchool of Medicine, University of Zagreb, Zagreb, Croatia.
University Hospital Centre Zagreb · HRAndrija Stampar Teaching Institute of Public Health · HRHrvatski zavod za javno zdravstvo · HRMedical University of Graz · ATUniversity of Dubrovnik · HRUniversity of Split · HRUniversity of Zagreb · HR

Funding

University of Zagreb BM13
6 · The paper itself

Abstract

Recently, emergence of carbapenem-resistance, in particular due to Klebsiella pneumoniae carbapenemase (KPC), was observed among K. pneumoniae causing urinary tract infections in Croatia. The aim of the study was to characterize, antimicrobial susceptibility, carbapenem resistance, virulence traits and plasmid types of the urinary KPC positive isolates of K. pneumoniae. The antimicrobial susceptibility to a wide range of antibiotics was determined by broth microdilution method. The transferability of meropenem resistance was determined by conjugation (broth mating method) employing Escherichia coli J63 strain resistant to sodium azide. Genes encoding broad and extended-spectrum β-lactamases, plasmid-mediated AmpC β-lactamases, group A and B carbapenemases, and carbapenem hydrolyzing oxacillinases (bla

Indexed as

Anti-Bacterial AgentsAzabicyclo CompoundsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCeftazidimeCroatiaDrug CombinationsEscherichia coliHumansKlebsiella InfectionsKlebsiella pneumoniaeMeropenemMicrobial Sensitivity TestsPlasmidsUrinary Tract InfectionsAmpC beta-lactamasesAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsBacterial Proteinsbeta-lactamase KPC-1beta-LactamasescarbapenemaseCeftazidimeDrug CombinationsMeropenemoxacillinaseKlebsiella pneumoniaeKPCResistanceUrinary tract infections

Identifiers

PMID33507339
OpenAlexW3123301146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.